LONDON, Oct. 4, 2017 /CNW/ - Pilatus Clinical Services are delighted to announce another addition to our management team. Mr Ian Hoban, previously Commercial Manager at Eli Lilly, will now fulfil the role of Sales & Marketing Director. Ian has close to 30 years of experience in the pharmaceutical industry, acting in a variety of roles including those of senior leadership at both Pfizer and Eli Lilly.
In his most recent position, Ian was responsible for managing the commercial development of numerous therapeutic brands, from development through to product launch and ultimately to loss-of-exclusivity. Ian is well-versed in the pharmaceutical supply chain and understands how getting the optimal solution in place is fundamental to the delivery of successful project outcomes.
Ian is no stranger to the clinical trials supply arena. Before his function as a Business Development Director, he held a consultative role at a major pharmaceutical company; helping deliver added value to their customers and partners following the acquisition of a number of diversified businesses.
‘Our commercial footprint is growing. With the incorporation of our sister company; PCS GmbH in Germany and future expansions in the pipeline, we are confident in achieving our goal of providing smarter comparator sourcing solutions to the clinical trial community. Myself, and the remaining board members are excited at the prospect of working with Ian to capitalise on these expansions and maximising Pilatus’ brand in the comparator sourcing space,’ said Julian Wolfe, Commercial Director at Pilatus Clinical Services.
Ian has a passion for collaboration and has seen how business partnerships can deliver strategic insight. At Pfizer UK, in the Established Products Business Unit, Ian oversaw the implementation of numerous techniques and witnessed how they transformed business outcomes in a highly competitive space.
This is another great advancement for the Pilatus group, improving our status as a leading service provider in comparator sourcing for clinical trials.
SOURCE Pilatus Clinical Services
For further information: durotimi@pilatuspharma.com, T: +44(0)1923-204310
